Canada Life’s Nurix Therapeutics NRIX Stock Holding History

Canada Life’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Buy	8,226 +3,590	+77%	+$61.2K	﹤0.01%	1594
2026 Q1	$72K	Hold	4,636	–	–	﹤0.01%	1721
2025 Q4	$88K	Hold	4,636	–	–	﹤0.01%	1728
2025 Q3	$43K	Hold	4,636	–	–	﹤0.01%	1823
2025 Q2	$53K	Hold	4,636	–	–	﹤0.01%	1826
2025 Q1	$55K	Buy	+4,636	New	+$77.5K	﹤0.01%	1852
2024 Q4	–	Sell	-4,876	Closed	-$110K	–	2055
2024 Q3	$110K	Hold	4,876	–	–	﹤0.01%	1855
2024 Q2	$102K	Buy	+4,876	New	+$75.9K	﹤0.01%	1873
2023 Q4	–	Sell	-1,891	Closed	-$15K	–	2204
2023 Q3	$15K	Hold	1,891	–	–	﹤0.01%	2175
2023 Q2	$19K	Hold	1,891	–	–	﹤0.01%	2159
2023 Q1	$17K	Hold	1,891	–	–	﹤0.01%	2239
2022 Q4	$21K	Hold	1,891	–	–	﹤0.01%	2248
2022 Q3	$25K	Buy	1,891 +1,119	+145%	+$17.7K	﹤0.01%	2225
2022 Q2	$10K	Hold	772	–	–	﹤0.01%	2361
2022 Q1	$11K	Hold	772	–	–	﹤0.01%	2425
2021 Q4	$22K	Hold	772	–	–	﹤0.01%	2361
2021 Q3	$23K	Sell	772 -756	-49%	-$23.3K	﹤0.01%	2401
2021 Q2	$41K	Buy	1,528 +888	+139%	+$26.1K	﹤0.01%	2327
2021 Q1	$20K	Hold	640	–	–	﹤0.01%	2506
2020 Q4	$21K	Buy	+640	New	+$21.2K	﹤0.01%	2530

Other funds holding NRIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Canada Life's NRIX Position: Q2 2026 in Review

Canada Life increased its Nurix Therapeutics (NRIX) stake by 77% in Q2 2026, buying an estimated $61.2K and bringing the position to 8,226 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

Canada Life first reported a position in NRIX in Q4 2020 and has held it in 20 quarters since. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

Canada Life held 8,226 shares of Nurix Therapeutics worth $199K as of Q2 2026.
Canada Life bought 3,590 Nurix Therapeutics shares in Q2 2026, an estimated $61.2K.
Nurix Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1594 holding.
Canada Life first reported a position in Nurix Therapeutics in Q4 2020 and has held it in 20 quarters since.
212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.